Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Review Article Volume 7 Issue 1

Jund Bedastar (Castoreum): Medicinal Potential of an Animal Origin Drug of Unani Medicine

Mohd Afsahul Kalam1*, Amjad Saifi2, Mohd Naved3 and Abdul Habib3

1Regional Research Institute of Unani Medicine, Naseembagh Campus, Habak, Srinagar, J&K, India
2Department of Moalajat, National Institute of Unani Medicine (NIUM), Bengaluru, Karnataka, India
3Department of Ilmul Advia, Regional Research Institute of Unani Medicine, University of Kashmir, Naseembagh Campus, Habak, Srinagar, J&K, India

*Corresponding Author: Mohd Afsahul Kalam, Research Officer (Unani), Regional Research Institute of Unani Medicine (CCRUM, Ministry of AYUSH, Govt. of India), Naseembagh Campus, Habak, Srinagar, J&K, India.

Received: December 01, 2022; Published: December 30, 2022

Abstract

Pharmaceutics in Unani System of Medicine (USM) comprises of medicinal plants, animal and minerals origin materials called Mawalid-i-Thalatha. The USM literature comprises description of many animal based drugs and medications, which was written by various imminent physicians. Jund Bedastar (castoreum) is one among the drug substances obtained from animal source. It is one of the most important drugs which have profound application in pharmaceuticals. It was used by Unani physicians since age old. It is used as main ingredient in various compound formulations such as Habb-i-Jund, Habb-i-Sar‘, Roghan Jund etc. This attempt has been made to accumulate all the scattered literature in one place for easy and better understanding and to explore the importance of Jund Bedastar with special reference to the therapeutic uses, adverse effect, substitution as per Unani perspective along with its bioactive compounds and pharmacological studies.

Keywords: Unani System of Medicine; Jund Bedastar; Epilepsy; Habb-i-Jund; Paralysis; Castoreum

References

  1. https://www.britannica.com/science/castoreum
  2. https://en.wikipedia.org/wiki/Beaverwebsites
  3. “National Formulary of Unani Medicine. Vol. 1st, Part II”. New Delhi: Central Council for Research in Unani Medicine. (2007): 21, 22, 23, 28, 29, 125, 181.
  4. Azam Khan M. “Muheet-i-Azam, Part II”. New Delhi: Central Council for Research in Unani Medicine. (2013): 220, 221, 223.
  5. Hubal B. “Kitab-ul-Mukhtarat fi’l Tibb, Part II, edn 1st”. New Delhi: Central Council for Research in Unani Medicine (2005): 95.
  6. Ibn Baitar. “Al-Jami Li Mufradat al-Advia wa al-Aghzia, Vol. 2, edn 2nd”. New Delhi: Central Council for Research in Unani Medicine. (2000): 428-431
  7. “Qarabadeen Sarkari”. New Delhi: Central Council for Research in Unani Medicine. (2006): 51.
  8. Najmul Ghani. “Khazain-ul-Advia”. New Delhi : Idara Kitab al-Shifa.” (2011): 567-569.
  9. Afsahul Kalam M. “Advia Haiwani wa Ma’dani (Animal and Mineral Origin Drugs)”. New Delhi: Hidayat Publishers and Distributors (2021): 35-37.
  10. Kabiruddin M. “Makhzanul Mufradat, edn 3rd”. New Delhi: Idara Kitab-ul-Shifa. (2014): 177.
  11. Ibn Sina. “Al-Qanoon, Vol II”. New Delhi: Aijaz Publishing House. (2010): 306.
  12. Arzani MA. “Qarabadeen Qadri”. New Delhi: Central Council for Research in Unani Medicine (2009): 32, 36, 79, 81, 89, 90, 186, 372, 374, 442, 443, 474, 480, 499, 500, 557, 594, 684, 771.
  13. Kabiruddin M. “Bayez-e-Kabeer, Vol II”. New Delhi: Central Council for Research in Unani Medicine (2008): 15, 29, 53, 179, 193, 194.
  14. “Al Qarabadeen”. New Delhi: Central Council for Research in Unani Medicine (2006): 483, 897, 1141-1142.
  15. “National Formulary of Unani Medicine, Part IV”. New Delhi: Central Council for Research in Unani Medicine. (2006): 30.
  16. “National Formulary of Unani Medicine, Part I”. New Delhi: Central Council for Research in Unani Medicine (2006): 13, 14, 21, 25, 30, 31, 202.
  17. “National Formulary of Unani Medicine Part IV”. New Delhi: Central Council for Research in Unani Medicine (2006): 12, 29, 71, 72, 109.
  18. “National Formulary of Unani Medicine Part VI”. New Delhi: Central Council for Research in Unani Medicine (2011): 21-22.
  19. “National Formulary of Unani Medicine. Part-V”. New Delhi: Central Council for Research in Unani Medicine (2008): 95-96.
  20. https://en.wikipedia.org/wiki/Castoreum
  21. Anupama Koneru., et al. “Protective Activity of Habb-i-Jund. A Unani Formulation against Convulsions in Mice”. Pharmacologyonline 3 (2009): 724-731.
  22. Anupama Koneru., et al. “In Vitro antioxidant activity of Habb-i-Jund (Unani Medicine) prescribed for febrile convulsions”. Pharmacologyonline 1 (2010): 943-949.
  23. Asjad HMM., et al. “In Vitro Antioxidant Activity of Habbe Sara [Unani Medicine]: Prescribed for Febrile Convulsions”. Journal of Pharmacy and Alternative Medicine 2 (2012): 29-35.

Citation

Citation: Mohd Afsahul Kalam., et al. “Jund Bedastar (Castoreum): Medicinal Potential of an Animal Origin Drug of Unani Medicine". Acta Scientific Pharmaceutical Sciences 7.1 (2023): 23-32.

Copyright

Copyright: © 2022 Mohd Afsahul Kalam., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate32%
Acceptance to publication20-30 days

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is July 10, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US